These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37787853)

  • 1. Variable fragmentation and ionization of amyloid-beta epimers and isomers.
    Readel ER; Dhaubhadel U; Patel A; Armstrong DW
    Anal Bioanal Chem; 2023 Nov; 415(27):6799-6807. PubMed ID: 37787853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complete identification of all 20 relevant epimeric peptides in β-amyloid: a new HPLC-MS based analytical strategy for Alzheimer's research.
    Du S; Readel ER; Wey M; Armstrong DW
    Chem Commun (Camb); 2020 Feb; 56(10):1537-1540. PubMed ID: 31922154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody binding of amyloid beta peptide epimers/isomers and ramifications for immunotherapies and drug development.
    Readel ER; Patel A; Putman JI; Du S; Armstrong DW
    Sci Rep; 2023 Jul; 13(1):12387. PubMed ID: 37524807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiating aspartic acid isomers and epimers with charge transfer dissociation mass spectrometry (CTD-MS).
    Edwards HM; Wu HT; Julian RR; Jackson GP
    Analyst; 2022 Mar; 147(6):1159-1168. PubMed ID: 35188507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of aspartic and isoaspartic acid residues in amyloid beta peptides, including Abeta1-42, using electron-ion reactions.
    Sargaeva NP; Lin C; O'Connor PB
    Anal Chem; 2009 Dec; 81(23):9778-86. PubMed ID: 19873993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid and selective separation of amyloid beta from its stereoisomeric point mutations implicated in neurodegenerative Alzheimer's disease.
    Readel ER; Wey M; Armstrong DW
    Anal Chim Acta; 2021 Jun; 1163():338506. PubMed ID: 34024415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Site-specific aspartic acid isomerization regulates self-assembly and neurotoxicity of amyloid-β.
    Sugiki T; Utsunomiya-Tate N
    Biochem Biophys Res Commun; 2013 Nov; 441(2):493-8. PubMed ID: 24383085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinguishing d- and l-aspartic and isoaspartic acids in amyloid β peptides with ultrahigh resolution ion mobility spectrometry.
    Zheng X; Deng L; Baker ES; Ibrahim YM; Petyuk VA; Smith RD
    Chem Commun (Camb); 2017 Jul; 53(56):7913-7916. PubMed ID: 28654112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drastic neuronal loss in vivo by beta-amyloid racemized at Ser(26) residue: conversion of non-toxic [D-Ser(26)]beta-amyloid 1-40 to toxic and proteinase-resistant fragments.
    Kaneko I; Morimoto K; Kubo T
    Neuroscience; 2001; 104(4):1003-11. PubMed ID: 11457586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-performance liquid chromatography coupled with tandem mass spectrometry for the detection of amyloid Beta peptide related with Alzheimer's disease.
    Du C; Ramaley C; McLean H; Leonard SC; Miller J
    J Biomol Tech; 2005 Dec; 16(4):356-63. PubMed ID: 16522857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liquid chromatography/tandem mass spectrometry characterization of oxidized amyloid beta peptides as potential biomarkers of Alzheimer's disease.
    Inoue K; Garner C; Ackermann BL; Oe T; Blair IA
    Rapid Commun Mass Spectrom; 2006; 20(5):911-8. PubMed ID: 16470704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ion mobility spectrometry combined with multivariate statistical analysis: revealing the effects of a drug candidate for Alzheimer's disease on Aβ1-40 peptide early assembly.
    Lazzaro S; Ogrinc N; Lamont L; Vecchio G; Pappalardo G; Heeren RMA
    Anal Bioanal Chem; 2019 Sep; 411(24):6353-6363. PubMed ID: 31407050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical modifications of amyloid-β(1-42) have a significant impact on the repertoire of brain amyloid-β(1-42) binding proteins.
    Medvedev AE; Buneeva OA; Kopylov AT; Mitkevich VA; Kozin SA; Zgoda VG; Makarov AA
    Biochimie; 2016; 128-129():55-8. PubMed ID: 27400251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atomic force microscopy and MD simulations reveal pore-like structures of all-D-enantiomer of Alzheimer's β-amyloid peptide: relevance to the ion channel mechanism of AD pathology.
    Connelly L; Jang H; Arce FT; Capone R; Kotler SA; Ramachandran S; Kagan BL; Nussinov R; Lal R
    J Phys Chem B; 2012 Feb; 116(5):1728-35. PubMed ID: 22217000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous determination of post-translational racemization and isomerization of N-terminal amyloid-β in Alzheimer's brain tissues by covalent chiral derivatized ultraperformance liquid chromatography tandem mass spectrometry.
    Inoue K; Hosaka D; Mochizuki N; Akatsu H; Tsutsumiuchi K; Hashizume Y; Matsukawa N; Yamamoto T; Toyo'oka T
    Anal Chem; 2014 Jan; 86(1):797-804. PubMed ID: 24283798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced ion mobility resolution of Abeta isomers from human brain using high-resolution demultiplexing software.
    Mukherjee S; Fjeldsted JC; Masters CL; Roberts BR
    Anal Bioanal Chem; 2022 Jul; 414(18):5683-5693. PubMed ID: 35426495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Racemization: its biological significance on neuropathogenesis of Alzheimer's disease.
    Mori H; Ishii K; Tomiyama T; Furiya Y; Sahara N; Asano S; Endo N; Shirasawa T; Takio K
    Tohoku J Exp Med; 1994 Nov; 174(3):251-62. PubMed ID: 7761990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative analysis of amyloid beta peptides in cerebrospinal fluid of Alzheimer's disease patients by immunoaffinity purification and stable isotope dilution liquid chromatography/negative electrospray ionization tandem mass spectrometry.
    Oe T; Ackermann BL; Inoue K; Berna MJ; Garner CO; Gelfanova V; Dean RA; Siemers ER; Holtzman DM; Farlow MR; Blair IA
    Rapid Commun Mass Spectrom; 2006; 20(24):3723-35. PubMed ID: 17117458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Separation of β-Amyloid Tryptic Peptide Species with Isomerized and Racemized l-Aspartic Residues with Ion Mobility in Structures for Lossless Ion Manipulations.
    Nagy G; Kedia K; Attah IK; Garimella SVB; Ibrahim YM; Petyuk VA; Smith RD
    Anal Chem; 2019 Apr; 91(7):4374-4380. PubMed ID: 30816701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of degradation products of aspartyl tripeptides by capillary electrophoresis-tandem mass spectrometry.
    De Boni S; Neusüss C; Pelzing M; Scriba GK
    Electrophoresis; 2003 Mar; 24(5):874-82. PubMed ID: 12627450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.